Clinical Manifestation of Severe Cases with COVID-19
- VernacularTitle:2019 新型冠状病毒肺炎重症病例临床特点分析
- Author:
Yun-feng SHI
1
;
Xiao-han SHI
1
;
Shi-wen LI
2
,
3
;
Yan-hong WANG
1
;
Jia-jia HU
1
;
Jun-hui BA
1
;
Wen-xiong XU
4
;
Ben-quan WU
1
Author Information
1. Department of MICU，Department of Pulmonary and Critical Care Medcine，The Third Affiliated Hospital of Sun Yat-sen University，Guangzhou 510630，China
2. Department of Pulmonary and Critical Care Medcine，Guangzhou Eighth People&prime
3. s Hospital，Guangzhou 510050，China
4. Department of Infectious Diseases，The Third Affiliated Hospital of Sun Yat-sen University，Guangzhou 510630，China
- Publication Type:Journal Article
- Keywords:
SARS-COV-2, pneumonia, severe case, clinical manifestation, prognosis
- From:
Journal of Sun Yat-sen University(Medical Sciences)
2020;41(2):184-190
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】To explore the clinical manifestation of COVID- 19 severe cases.【Methods】Clinical data of one severe case with COVID-19 including the clinical characteristic ，laboratory testing results，radiography，treatment，complication and outcome of the patient were retrospectively collected and analyzed.【Results】 The patient with COVID-19 was a 61-year old male，He suffered with underlying disease. His symptoms included fever，cough，myalgia， fatigue，and dyspnea. Laboratory testing results included normal WBC count，decreased lymphocyte cells，elevated LDH and hypoxemia. Radiography findings showed bilateral lung infiltration. His condition deteriorated after intensive treatment for one week. He was intubated and treated with mechanical ventilation because of complicating with severe acute respiratory distress syndrome（ARDS）.【Conclusion】COVID-19 is an emerging acute communicable disease，which lack specific and effective treatment. Most patients have a good prognosis but mortality in severe cases is high. More attention should be paid on the high risk of progression in COVID-19 cases.
